Attached files
| file | filename |
|---|---|
| EX-31.2 - Emergent BioSolutions Inc. | exhibit31_2.htm |
| EX-23.1 - Emergent BioSolutions Inc. | exhibit23_1.htm |
| EX-21.1 - Emergent BioSolutions Inc. | exhibit21_1.htm |
| EX-32.2 - Emergent BioSolutions Inc. | exhibit32_2.htm |
| EX-31.1 - Emergent BioSolutions Inc. | exhibit31_1.htm |
| EX-10.50 - Emergent BioSolutions Inc. | exhibit10_50.htm |
| EX-10.49 - Emergent BioSolutions Inc. | exhibit10_49.htm |
| 10-K - Emergent BioSolutions Inc. | form10-k_2010.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Emergent BioSolutions Inc. (the "Company") for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Fuad El-Hibri, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 10, 2011
/s/Fuad El-Hibri
Fuad El-Hibri
Chief Executive Officer